Treating HCV Infection: It Doesn’t Get Much Better Than This
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians. With 8 FDA approved treatment regimens for chronic HCV, there are many great options for all oral therapy and access has been extended to the (more…)
The Greatest Public Health Crisis Among People With HIV: Opioids in America
Overview Assessment of Needs This webinar will examine the epidemiology of opioids in America, the basics of opioid use disorder, and its treatment in HIV clinical settings. This is a practical webinar to provide frontline providers with the information and skills to improve their practice as they work with people who use opioids. Learning Objectives (more…)
HIV and Cardiovascular Disease: A Tale of Two Epidemics
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. This webinar will summarize the epidemiology and pathogenesis of cardiovascular disease in people living with HIV, with a focus on coronary heart disease. It will (more…)
A Small-Group Workshop on Evolving Strategies in Hepatitis C Management
View the agenda Venue and Travel Information View the modular e-syllabus with the final presentations slides NOTE: On-site registration will be on a first-come first-served basis and limited to clinical decision makers (physicians, nurse practitioners, and physician assistants) and PharmDs. The On-site fee is $75.00 (USD). Overview Assessment of Needs HCV disease management has seen rapid advances, (more…)
“Flexner’s Fabulous Formulations!” A Review of Long-Acting Antiretrovirals and Other New Investigational Drugs for HIV Infection
Overview Assessment of Needs Long-acting antiretroviral formulations have the potential to improve convenience and adherence compared with standard daily oral regimens. This webinar will review new investigational drugs, including long-acting formulations that are in preclinical and clinical development. There will also be a discussion on challenges in using these agents, including managing adverse effects and drug-drug (more…)
A Small-Group Workshop on Evolving Strategies in Hepatitis C Management
View the agenda Venue and Travel Information View the modular e-syllabus with the final presentation slides NOTE: Registration will be limited to clinical decision makers (physicians, nurse practitioners, and physician assistants) and PharmDs. To foster discussion the ideal group size is 25 to 35 attendees. Overview Assessment of Needs HCV disease management has seen rapid (more…)
A Small-Group Workshop on Evolving Strategies in Hepatitis C Management
View the agenda Venue and Travel Information View the modular e-syllabus with the final presentation slides NOTE: There will be no on-site registration. This workshop has reached capacity and registration is closed. There is space available for our HCV management workshop in: Charleston, SC, on November 2, 2018 (www.iasusa.org/events/fall-2018-south-carolina-cme-workshop) Registration is limited to clinical decision (more…)
What to Do After Hepatitis C Virus Infection Cure
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians. This webinar will cover the issues that persist after hepatitis C virus (HCV) infection cure and how practitioners can determine which patients should be monitored (more…)
A Small-Group Workshop on Evolving Strategies in Hepatitis C Management
View the agenda Venue and Travel Information View the modular e-syllabus with the final presentation slides NOTE: On-site registration will be on a first-come first-served basis and limited to clinical decision makers (physicians, nurse practitioners, and physician assistants) and PharmDs. The On-site fee is $75.00 (USD). Overview Assessment of Needs HCV disease management has seen rapid advances, (more…)
A Small-Group Workshop on Evolving Strategies in Hepatitis C Management
View the agenda Venue and Travel Information View the modular e-syllabus with the final presentation slides NOTE: On-site registration will be on a first-come first-served basis and limited to clinical decision makers (physicians, nurse practitioners, and physician assistants) and PharmDs. The On-site fee is $75.00 (USD). Overview Assessment of Needs HCV disease management has seen rapid advances, (more…)